Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic

Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma - ScienceDirect

The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma, Experimental Hematology & Oncology

Preventing osteolytic lesions and osteomyelitis in multiple myeloma - ScienceDirect

OUH - Group members

Biomedicines, Free Full-Text

OUH - About our research

Progression-free (PFS) and overall survival (OS) landmark analysis from

Health-related quality of life in the ENDEAVOR study: carfilzomib- dexamethasone vs bortezomib-dexamethasone in relapsed/refractory multiple myeloma

Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life. - Abstract - Europe PMC

Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option

OUH - Group members